European stocks gained as investor sentiment received a boost from better-than-expected US personal spending data, overshadowing plans by President Donald Trump to slap tariffs on patented drugs. The Stoxx Europe 600 Index rose  at the close. The healthcare sector erased earlier losses to gain 0.1% after Trump said he plans a 100% duty on patented drugs effective Oct. 1, unless the producer is building a manufacturing plant in the US. Novo Nordisk A/S fell  and Zealand Pharma A/S retreated . Most Read fr ...

US stocks rose on Wednesday, eyeing a return to their record-setting run as Alibaba's (BABA) spending plans lifted hopes for a continuation of the AI-fueled tech rally. The tech-heavy Nasdaq Composite (^IXIC) and the Dow Jones Industrial Average (^DJI) moved up nearly 0.3%, while the S&P 500 (^GSPC) nudged around 0.2% higher. Tech stocks are shaping up for a slight comeback, after the major gauges snapped a win streak on Tuesday amid losses for "Magnificent Seven" megacaps. Alibaba stock jumped over 8% ...